Login to Your Account

Financings Roundup

StemCells Prices $20M Offering For Adult Stem Cell Programs

By Catherine Shaffer
BioWorld Today Contributing Writer

Monday, December 19, 2011
A new public offering of 8 million stock units and 8 million Series B warrants could raise up to $20 million for StemCells Inc., of Newark, Calif. The company just completed enrollment in a Phase I/II trial of its HuCNS-SC neural stem cells in chronic spinal cord injury.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription